Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

SCTLSCTL
23 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in RECRO PHARMA INC

No. BNP Paribas Financial Markets exited its SCTL (Recro Pharma) position in Q2 2024. Its Q1 2024 13F listed 257 shares worth $278. BNP Paribas Financial Markets already held SCTL in its Q4 2018 13F, the earliest on record, and held it in 22 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$36

Total Shares Change

-5

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q2
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q1
Unchanged
257
0.0%
$2780.0%—
0
2023-Q4
Unchanged
257
0.0%
$900.0%—
0
2023-Q3
Unchanged
257
0.0%
$1210.0%—
0
2023-Q2
Unchanged
257
0.0%
$2830.0%—
0
2023-Q1
Decreased
257
-18.9%
$3060.0%—
0
2022-Q4
Unchanged
317
0.0%
$4720.0%—
0
2022-Q3
Unchanged
317
0.0%
$5170.0%—
0
2022-Q2
Unchanged
317
0.0%
$2520.0%—
0
2022-Q1
Unchanged
317
0.0%
$5710.0%—
0
2021-Q4
Unchanged
317
0.0%
$5420.0%—
0
2021-Q3
Decreased
317
-94.8%
$6530.0%—
0
2021-Q2
Increased
6,095
+38.6%
$14,0790.0%—
16
2021-Q1
Increased
4,396
+12.8%
$12,2650.0%—
13
2020-Q4
Decreased
3,899
-20.8%
$11,1120.0%—
0
2020-Q3
Increased
4,921
+618.4%
$10,3340.0%—
19
2020-Q2
Decreased
685
-88.8%
$3,1170.0%—
0
2020-Q1
Increased
6,102
+105.2%
$49,8530.0%—
33
2019-Q4
Increased
2,974
+2.2%
$54,5130.0%—
21
2019-Q3
Increased
2,911
+44.1%
$32,2540.0%—
27
2019-Q2
Decreased
2,020
-46.2%
$20,5430.0%—
0
2019-Q1
Increased
3,752
+749x
$21,9870.0%—
21
2018-Q4
First report
5
-
$360.0%—
0

Other major holders of SCTL: RENAISSANCE TECHNOLOGIES LLC, PANAGORA ASSET MANAGEMENT INC, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used